MS drug Tysabri leukoencephalopathy risk factors identified
|
Multiple sclerosis patients taking natalizumab are at higher risk of developing progressive multifocal leukoencephalopathy (PML) if they are positive for the anti-JC virus antibodies, have been treated with immunosuppressants, and have been treated with natalizumab for longer periods, accord... [New To The MSRC Website?
Virgin London Marathon
World MS Day (Green Day)
World MS Day is the day of the year we ask everyone to ‘Go Green’ & raise MS awareness & support MSRC
Find out how here.
